HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cutaneous and subcutaneous necrosis following dexrazoxane-CHOP therapy.

AuthorsI S Lossos, D Ben-Yehuda
JournalThe Annals of pharmacotherapy (Ann Pharmacother) Vol. 33 Issue 2 Pg. 253-4 (Feb 1999) ISSN: 1060-0280 [Print] United States
PMID10084428 (Publication Type: Case Reports, Letter)
Chemical References
  • Cardiovascular Agents
  • Razoxane
  • Vincristine
  • Doxorubicin
  • Cyclophosphamide
  • Prednisone
Topics
  • Adult
  • Antineoplastic Combined Chemotherapy Protocols (adverse effects)
  • Cardiovascular Agents (adverse effects)
  • Cyclophosphamide (adverse effects)
  • Doxorubicin (adverse effects)
  • Fatal Outcome
  • Female
  • Humans
  • Lymphoma, B-Cell (drug therapy)
  • Lymphoma, Large B-Cell, Diffuse (drug therapy)
  • Lymphoma, Non-Hodgkin (drug therapy)
  • Necrosis
  • Prednisone (adverse effects)
  • Razoxane (adverse effects)
  • Skin (pathology)
  • Vincristine (adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: